6:05 PM
 | 
Nov 06, 2012
 |  BC Extra  |  Company News

Takeda to acquire Envoy

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire partner Envoy Therapeutics Inc. (Jupiter, Fla.) for up to $140 million in cash, including an upfront payment and preclinical milestones. Takeda, which has...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >